Levamisole therapy in chronic type B hepatitis
- 1 September 1986
- journal article
- research article
- Published by Elsevier in Gastroenterology
- Vol. 91 (3) , 692-696
- https://doi.org/10.1016/0016-5085(86)90640-2
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Clinical, Virologic and Histologic Outcome Following Seroconversion From Hbeag to Anti–Hbe in Chronic Hepatitis Type BHepatology, 1986
- Relationship between HBcAg in serum and liver and HBV replication in patients with HBsAg‐positive chronic liver diseaseJournal of Medical Virology, 1985
- Virus replication and liver disease in chronic hepatitis B virus infectionDigestive Diseases and Sciences, 1983
- Changes in hepatitis Be antigen/antibody system in children with chronic hepatitis B virus infectionThe Journal of Pediatrics, 1983
- Seroconversion from Hepatitis B e Antigen to Antibody in Chronic Type B HepatitisAnnals of Internal Medicine, 1981
- The General Immunopharmacology of LevamisoleDrugs, 1980
- Immunological aspects of hepatitis B virus infectionThe Lancet Healthy Longevity, 1975
- INADEQUATE ANTIBODY RESPONSE TO HBAg OR SUPPRESSOR T-CELL DEFECT IN DEVELOPMENT OF ACTIVE CHRONIC HEPATITISThe Lancet, 1974
- Cell-mediated Immunity in Patients Positive for Hepatitis-associated AntigenBMJ, 1972
- A CLASSIFICATION OF CHRONIC HEPATITISThe Lancet, 1968